CRCL has decisively flipped the script on the bear thesis this week: the stock is up 12.5% to $71.16, short sellers are covering at pace, and analysts who spent last week slashing targets are already revising upward — a sharp reversal from the grinding pressure documented in recent notes.
The most striking data shift is in short interest. Bears have retreated meaningfully. SI has dropped to 11.6% of the free float from the 12.9% flagged in the August 7 note — a 9.4% single-week reduction in shares short, the sharpest cover move seen over the 30-day window. That said, 11.6% remains a high absolute level for a name this young, and the one-month trend is still net positive for bears, up roughly 5% from where it sat in early July. The borrow market tells a nuanced story alongside the covering. Availability has tightened from the 164% range seen earlier in the week to 149% — still in moderate-supply territory, meaning there is no mechanical squeeze pressure, but the direction has shifted notably from the 270%-plus levels in place six weeks ago. Cost to borrow has climbed 29% on the week to 0.55%, hitting its highest level in the 30-day window. That combination — covering plus rising borrow cost — suggests the shorts who remain are facing incrementally more friction. Options traders, by contrast, are unmoved. The put/call ratio has drifted to 0.74, essentially in line with its 20-day average of 0.75, and the z-score of -0.39 places it well within normal range. No hedging surge, no directional conviction from the derivatives desk.
The Street is split in a way that captures the genuine uncertainty around this name. TD Cowen's Bryan Bergin raised his target to $87 on August 12, building on his August 3 initiation — the only bullish revision this week. That sits in contrast to the cluster of target cuts filed last week: Canaccord trimmed from $160 to $130, Needham from $150 to $127, and HC Wainwright from $115 to $104, all while maintaining Buy ratings. Morgan Stanley held its Underweight with a $37 target. The mean consensus target is $103, implying roughly 45% upside from current levels — though Mizuho's upgrade to Neutral at $45, filed on July 31, stands as a reminder that several houses see the stock as already fairly valued or worse at these prices. The bull case centers on USDC circulation growth of 72% year-on-year to $75.3 billion and total revenue up 77%, with market share in stablecoin transaction volume nearly doubling from 39% to close to 50% in a single quarter. Bears counter that declining interest rates compress reserve yield revenues, and that the Circle Payments Network has disappointed on adoption. The ORTEX short score of 64.1 and a short score rank in just the 9th percentile signal that the data still skews cautious, even after this week's covering.
Institutional flows add a layer of complexity. BlackRock added 3.3 million shares as of July 31, making it the most significant institutional buyer in the recent period. ARK and State Street also built positions. On the other side, Marshall Wace trimmed sharply — down 4.2 million shares to 5.8 million. Founder and CEO Jeremy Allaire sold approximately $1.5 million worth of stock across multiple tranches on August 5, the same day as the earnings print, while an independent director sold $1.2 million on August 6. The sales are mechanically modest relative to Allaire's 6.4% stake, and the significance scores are low, but the timing alongside the earnings release will attract scrutiny. The net 90-day insider figure remains a small positive at just over 100,000 shares, so this does not read as a coordinated distribution — but it is worth noting.
The August 10 earnings print delivered a 6.7% one-day gain, a clean beat relative to the near-flat reaction on August 5. The key variable to track from here is whether the covering shorts accelerate, given that 11.6% of float remains a substantial position against a name with a mean analyst target nearly 45% above the current price, and whether the borrow cost rise toward 0.55% represents the start of a more meaningful tightening or simply post-earnings noise.
See the live data behind this article on ORTEX.
Open CRCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
